HEADER DNA BINDING PROTEIN 26-MAY-23 8JIG TITLE A NOVEL UHRF1-TARGETED COMPOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE UHRF1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: INVERTED CCAAT BOX-BINDING PROTEIN OF 90 KDA,NUCLEAR PROTEIN COMPND 5 95,NUCLEAR ZINC FINGER PROTEIN NP95,HUNP95,HNP95,RING FINGER PROTEIN COMPND 6 106,RING-TYPE E3 UBIQUITIN TRANSFERASE UHRF1,TRANSCRIPTION FACTOR COMPND 7 ICBP90,UBIQUITIN-LIKE PHD AND RING FINGER DOMAIN-CONTAINING PROTEIN COMPND 8 1,HUHRF1,UBIQUITIN-LIKE-CONTAINING PHD AND RING FINGER DOMAINS COMPND 9 PROTEIN 1; COMPND 10 EC: 2.3.2.27; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: UHRF1, ICBP90, NP95, RNF106; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS UHRF1, PROSTATE CANCER, DNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.CHEN,L.JIANG REVDAT 1 29-MAY-24 8JIG 0 JRNL AUTH Y.CHEN,L.JIANG JRNL TITL A NOVEL UHRF1-TARGETED COMPOUND JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.65 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 3 NUMBER OF REFLECTIONS : 17240 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1721 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 2.4707 - 2.4001 1.00 0 154 0.2604 0.3418 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8JIG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 03-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1300037964. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17248 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.1100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: HKL-3000 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BRIS-TRIS, PH 6.0, 0.2M NACL, REMARK 280 1MM TCEP, 2.2-2.4MM AMMONIUM SULFATE, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.87800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 63.75600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 413 REMARK 465 ARG A 484 REMARK 465 ASP A 485 REMARK 465 LEU A 486 REMARK 465 SER A 487 REMARK 465 GLY A 488 REMARK 465 ASN A 489 REMARK 465 LYS A 490 REMARK 465 ARG A 491 REMARK 465 THR A 492 REMARK 465 ALA A 493 REMARK 465 GLU A 494 REMARK 465 GLN A 495 REMARK 465 SER A 496 REMARK 465 HIS A 620 REMARK 465 HIS A 621 REMARK 465 HIS A 622 REMARK 465 HIS A 623 REMARK 465 HIS A 624 REMARK 465 MET B 413 REMARK 465 ARG B 484 REMARK 465 ASP B 485 REMARK 465 LEU B 486 REMARK 465 SER B 487 REMARK 465 GLY B 488 REMARK 465 ASN B 489 REMARK 465 LYS B 490 REMARK 465 ARG B 491 REMARK 465 THR B 492 REMARK 465 ALA B 493 REMARK 465 GLU B 494 REMARK 465 GLN B 495 REMARK 465 SER B 496 REMARK 465 HIS B 620 REMARK 465 HIS B 621 REMARK 465 HIS B 622 REMARK 465 HIS B 623 REMARK 465 HIS B 624 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 500 CE NZ REMARK 470 LYS A 568 CD CE NZ REMARK 470 LYS A 570 CG CD CE NZ REMARK 470 PHE A 573 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 595 CE NZ REMARK 470 LYS A 599 CD CE NZ REMARK 470 LYS A 600 CD CE NZ REMARK 470 LYS B 500 CE NZ REMARK 470 LYS B 568 CD CE NZ REMARK 470 LYS B 570 CG CD CE NZ REMARK 470 PHE B 573 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 595 CE NZ REMARK 470 LYS B 599 CD CE NZ REMARK 470 LYS B 600 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG B 581 O01 8JA B 701 1.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 581 NE - CZ - NH1 ANGL. DEV. = 4.3 DEGREES REMARK 500 ARG B 581 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 416 32.45 -99.70 REMARK 500 VAL A 446 -53.42 -125.81 REMARK 500 ASP A 455 -147.08 -154.52 REMARK 500 ALA A 463 53.12 -143.23 REMARK 500 ASN A 503 -129.89 52.66 REMARK 500 ASP A 526 64.01 -108.78 REMARK 500 SER A 545 116.85 -162.98 REMARK 500 VAL B 446 -53.01 -126.20 REMARK 500 ASP B 455 -147.30 -154.25 REMARK 500 ALA B 463 53.56 -141.38 REMARK 500 ASN B 503 -128.71 51.31 REMARK 500 ASP B 526 63.23 -106.53 REMARK 500 SER B 545 117.14 -165.05 REMARK 500 REMARK 500 REMARK: NULL DBREF 8JIG A 414 617 UNP Q96T88 UHRF1_HUMAN 414 617 DBREF 8JIG B 414 617 UNP Q96T88 UHRF1_HUMAN 414 617 SEQADV 8JIG MET A 413 UNP Q96T88 INITIATING METHIONINE SEQADV 8JIG ALA A 618 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG HIS A 619 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG HIS A 620 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG HIS A 621 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG HIS A 622 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG HIS A 623 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG HIS A 624 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG MET B 413 UNP Q96T88 INITIATING METHIONINE SEQADV 8JIG ALA B 618 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG HIS B 619 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG HIS B 620 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG HIS B 621 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG HIS B 622 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG HIS B 623 UNP Q96T88 EXPRESSION TAG SEQADV 8JIG HIS B 624 UNP Q96T88 EXPRESSION TAG SEQRES 1 A 212 MET PRO SER ASN HIS TYR GLY PRO ILE PRO GLY ILE PRO SEQRES 2 A 212 VAL GLY THR MET TRP ARG PHE ARG VAL GLN VAL SER GLU SEQRES 3 A 212 SER GLY VAL HIS ARG PRO HIS VAL ALA GLY ILE HIS GLY SEQRES 4 A 212 ARG SER ASN ASP GLY ALA TYR SER LEU VAL LEU ALA GLY SEQRES 5 A 212 GLY TYR GLU ASP ASP VAL ASP HIS GLY ASN PHE PHE THR SEQRES 6 A 212 TYR THR GLY SER GLY GLY ARG ASP LEU SER GLY ASN LYS SEQRES 7 A 212 ARG THR ALA GLU GLN SER CYS ASP GLN LYS LEU THR ASN SEQRES 8 A 212 THR ASN ARG ALA LEU ALA LEU ASN CYS PHE ALA PRO ILE SEQRES 9 A 212 ASN ASP GLN GLU GLY ALA GLU ALA LYS ASP TRP ARG SER SEQRES 10 A 212 GLY LYS PRO VAL ARG VAL VAL ARG ASN VAL LYS GLY GLY SEQRES 11 A 212 LYS ASN SER LYS TYR ALA PRO ALA GLU GLY ASN ARG TYR SEQRES 12 A 212 ASP GLY ILE TYR LYS VAL VAL LYS TYR TRP PRO GLU LYS SEQRES 13 A 212 GLY LYS SER GLY PHE LEU VAL TRP ARG TYR LEU LEU ARG SEQRES 14 A 212 ARG ASP ASP ASP GLU PRO GLY PRO TRP THR LYS GLU GLY SEQRES 15 A 212 LYS ASP ARG ILE LYS LYS LEU GLY LEU THR MET GLN TYR SEQRES 16 A 212 PRO GLU GLY TYR LEU GLU ALA LEU ALA ASN ALA HIS HIS SEQRES 17 A 212 HIS HIS HIS HIS SEQRES 1 B 212 MET PRO SER ASN HIS TYR GLY PRO ILE PRO GLY ILE PRO SEQRES 2 B 212 VAL GLY THR MET TRP ARG PHE ARG VAL GLN VAL SER GLU SEQRES 3 B 212 SER GLY VAL HIS ARG PRO HIS VAL ALA GLY ILE HIS GLY SEQRES 4 B 212 ARG SER ASN ASP GLY ALA TYR SER LEU VAL LEU ALA GLY SEQRES 5 B 212 GLY TYR GLU ASP ASP VAL ASP HIS GLY ASN PHE PHE THR SEQRES 6 B 212 TYR THR GLY SER GLY GLY ARG ASP LEU SER GLY ASN LYS SEQRES 7 B 212 ARG THR ALA GLU GLN SER CYS ASP GLN LYS LEU THR ASN SEQRES 8 B 212 THR ASN ARG ALA LEU ALA LEU ASN CYS PHE ALA PRO ILE SEQRES 9 B 212 ASN ASP GLN GLU GLY ALA GLU ALA LYS ASP TRP ARG SER SEQRES 10 B 212 GLY LYS PRO VAL ARG VAL VAL ARG ASN VAL LYS GLY GLY SEQRES 11 B 212 LYS ASN SER LYS TYR ALA PRO ALA GLU GLY ASN ARG TYR SEQRES 12 B 212 ASP GLY ILE TYR LYS VAL VAL LYS TYR TRP PRO GLU LYS SEQRES 13 B 212 GLY LYS SER GLY PHE LEU VAL TRP ARG TYR LEU LEU ARG SEQRES 14 B 212 ARG ASP ASP ASP GLU PRO GLY PRO TRP THR LYS GLU GLY SEQRES 15 B 212 LYS ASP ARG ILE LYS LYS LEU GLY LEU THR MET GLN TYR SEQRES 16 B 212 PRO GLU GLY TYR LEU GLU ALA LEU ALA ASN ALA HIS HIS SEQRES 17 B 212 HIS HIS HIS HIS HET 8JA A 701 21 HET 8JA B 701 21 HETNAM 8JA N-[2,4-BIS(OXIDANYLIDENE)-1H-PYRIMIDIN-5-YL]-N'- HETNAM 2 8JA OXIDANYL-OCTANEDIAMIDE FORMUL 3 8JA 2(C12 H18 N4 O5) FORMUL 5 HOH *144(H2 O) HELIX 1 AA1 PHE A 432 GLY A 440 1 9 HELIX 2 AA2 THR A 502 CYS A 512 1 11 HELIX 3 AA3 ASP A 526 GLY A 530 5 5 HELIX 4 AA4 LYS A 540 SER A 545 5 6 HELIX 5 AA5 THR A 591 GLY A 602 1 12 HELIX 6 AA6 GLY A 610 ASN A 617 1 8 HELIX 7 AA7 PHE B 432 GLY B 440 1 9 HELIX 8 AA8 THR B 502 CYS B 512 1 11 HELIX 9 AA9 ASP B 526 GLY B 530 5 5 HELIX 10 AB1 LYS B 540 SER B 545 5 6 HELIX 11 AB2 THR B 591 GLY B 602 1 12 HELIX 12 AB3 GLY B 610 ASN B 617 1 8 SHEET 1 AA1 5 ILE A 449 GLY A 451 0 SHEET 2 AA1 5 ALA A 457 LEU A 462 -1 O SER A 459 N HIS A 450 SHEET 3 AA1 5 VAL A 533 ASN A 538 1 O ASN A 538 N LEU A 462 SHEET 4 AA1 5 ASN A 553 LYS A 568 -1 O ASP A 556 N VAL A 535 SHEET 5 AA1 5 ALA A 522 GLU A 523 -1 N ALA A 522 O TYR A 564 SHEET 1 AA2 5 PHE A 475 THR A 479 0 SHEET 2 AA2 5 LEU A 574 ARG A 582 -1 O TYR A 578 N TYR A 478 SHEET 3 AA2 5 ASN A 553 LYS A 568 -1 N GLU A 567 O VAL A 575 SHEET 4 AA2 5 MET A 429 TRP A 430 -1 N TRP A 430 O ASN A 553 SHEET 5 AA2 5 MET A 605 GLN A 606 1 O GLN A 606 N MET A 429 SHEET 1 AA3 4 MET B 429 TRP B 430 0 SHEET 2 AA3 4 ASN B 553 LYS B 568 -1 O ASN B 553 N TRP B 430 SHEET 3 AA3 4 LEU B 574 ARG B 582 -1 O VAL B 575 N GLU B 567 SHEET 4 AA3 4 PHE B 475 THR B 479 -1 N TYR B 478 O TYR B 578 SHEET 1 AA4 5 ILE B 449 GLY B 451 0 SHEET 2 AA4 5 ALA B 457 LEU B 462 -1 O SER B 459 N HIS B 450 SHEET 3 AA4 5 VAL B 533 ASN B 538 1 O ASN B 538 N LEU B 462 SHEET 4 AA4 5 ASN B 553 LYS B 568 -1 O TYR B 559 N VAL B 533 SHEET 5 AA4 5 ALA B 522 GLU B 523 -1 N ALA B 522 O TYR B 564 CISPEP 1 GLY A 482 GLY A 483 0 -5.46 CRYST1 65.875 65.875 95.634 90.00 90.00 120.00 P 31 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015180 0.008764 0.000000 0.00000 SCALE2 0.000000 0.017529 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010457 0.00000